Anticancer effect of icaritin on human lung cancer cells through inducing s phase cell cycle arrest and apoptosis

Abstract

Icaritin, a prenylflavonoid derivative from Epimedium Genus, has been shown to exhibit many pharmacological and biological activities. However, the function and the underlying mechanisms of icaritin in human non-small cell lung cancer have not been fully elucidated. The purpose of this study was to investigate the anticancer effects of icaritin on A549 cells and explore the underlying molecular mechanism. The cell viability after icaritin treatment was tested by MTT assay. The cell cycle distribution, apoptosis and reactive oxygen species (ROS) levels were analyzed by flow cytometry. The mRNA and protein expression levels of the genes involved in proliferation and apoptosis were respectively detected by RT-PCR and Western blotting. The results demonstrated that icaritin induced cell cycle arrest at S phase, and down-regulated the expression levels of S regulatory proteins such as Cyclin A and CDK2. Icaritin also induced cell apoptosis characterized by positive Hoechst 33258 staining, accumulation of the Annexin V-positive cells, increased ROS level and alteration in Bcl-2 family proteins expression. Moreover, icaritin induced sustained phosphorylation of ERK and p38 MAPK. These findings suggested that icaritin might be a new potent inhibitor by inducing S phase arrest and apoptosis in human lung carcinoma A549 cells.

Keywords

icaritin / A549 cells / apoptosis / ERK / p38 MAPK

References

[1] JiangL, LuoM, LiuD, et al.. BAD overexpression inhibits cell growth and induces apoptosis via mitochondrial-dependent pathway in non-small cell lung cancer. Cancer Cell Int, 2013, 13(1): 53

[2] RoomiMW, KalinovskyT, NiedzwieckiA, et al.. Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in human lung cancer and mesothelioma cell lines. Int J Oncol, 2013, 42(6): 1883-1889

[3] JemalA, SiegelR, WardE, et al.. Cancer statistics. CA Cancer J Clin, 2009, 59(4): 225-249

[4] ZhuDY, LouYJ. Inducible effects of icariin, icaritin, and desmethylicaritin on directional differentiation of embryonic stem cells into cardiomyocytes in vitro. Acta Pharmacol Sin, 2005, 26(4): 477-485

[5] ZhangG, QinL, ShengH, et al.. A novel semisynthesized small molecule icaritin reduces incidence of steroid-associated osteonecrosis with inhibition of both thrombosis and lipid-deposition in a dose-dependent manner. Bone, 2009, 44(2): 345-356

[6] WangZ, ZhangX, WangH, et al.. Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway. Neuroscience, 2007, 145(3): 911-922

[7] HuangJ, YuanL, WangX, et al.. Icaritin and its glycosides enhance osteoblastic, but suppress osteoclastic, differentiation and activity in vitro. Life Sci, 2007, 81(10): 832-840

[8] LiQH, HuaiL, ZhangCP, et al.. Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways. Int J Hematol, 2013, 97(5): 617-623

[9] GuoYM, ZhangXT, MengJ, et al.. An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cells. Eur J Pharmacol, 2011, 658(2–3): 114-122

[10] WangZQ, LouYJ. Proliferation-stimulating effects of icaritin and desmethylicaritin in MCF-7 cells. Eur J Pharmacol, 2004, 504(3): 147-153

[11] HuangX, ZhuDY, LouY. A novel anticancer agent, icaritin, induced cell growth inhibition, G(1) arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells. Eur J Pharmacol, 2007, 564(1–3): 26-36

[12] TongJS, ZhangQH, HuangX, et al.. Icaritin causes sustained ERK1/2 activation and induces apoptosis in human endometrial cancer cells. PLoS One, 2011, 6(3): e16781

[13] HeJ, WangY, DuanF, et al.. Icaritin induces apoptosis of HepG2 cells via the JNK1 signaling pathway independent of the estrogen receptor. Planta Med, 2010, 76(16): 1834-1839

[14] MirzayansR, AndraisB, ScottA, et al.. New insights into p53 signaling and cancer cell response to DNA damage: implications for cancer therapy. J Biomed Biotechnol, 2012, 2012: 170325

[15] VogelsteinB, LaneD, LevineAJ. Surfing the p53 network. Nature, 2000, 408(6810): 307-310

[16] ZhangY, XuXM, HeP. Tubeimoside-1 inhibits proliferation and induces apoptosis by increasing the Bax to Bcl-2 ratio and decreasing COX-2 expression in lung cancer A549 cells. Mol Med Rep, 2011, 4(1): 25-29

[17] XiaoD, PowolnyAA, MouraMB, et al.. Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J Biol Chem, 2010, 285(34): 26 558-26 569

[18] ZhuQ, WangJ, ZhangY, et al.. Mechanisms of MPP(+)-induced PC12 cell apoptosis via reactive oxygen species. J Huazhong Univ Sci Technolog Med Sci, 2012, 32(6): 861-866

[19] XiaoD, PowolnyAA, SinghSV. Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells. J Biol Chem, 2008, 283(44): 30 151-30 163

[20] OltersdorfT, ElmoreSW, ShoemakerAR, et al.. An inhibitor of Bcl-2 family proteins induces regression of solid tumors. Nature, 2005, 435(7042): 677-681

[21] Metrailler-RuchonnetI, PaganoA, CarnesecchiS, et al.. Bcl-2 protects against hyperoxia-induced apoptosis through inhibition of the mitochondria-dependent pathway. Free Radic Biol Med, 2007, 42(7): 1062-1074

[22] YangHL, ChenCS, ChangWH, et al.. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by Antrodia camphorata. Cancer Lett, 2006, 231(2): 215-227

[23] YaoY, HuangC, LiZF, et al.. Exogenous phosphatidylethanolamine induces apoptosis of human hepatoma HepG2 cells via the bcl-2/bax pathway. World J Gastroenterol, 2009, 15(14): 1751-1758

[24] JiangTS, ZhouLP, ZhangWL, et al.. Effects of sinomenine on proliferation and apoptosis in human lung cancer cell line NCI-H460 in vitro. Mol Med Rep, 2010, 3(1): 51-56

[25] GenG, ZhaoYP, YangL, et al.. Anti-proliferative effect of clitocine from the mushroom Leucopaxillus giganteus on human cervical cancer HeLa cells by inducing apoptosis. Cancer Lett, 2008, 262(2): 190-200

[26] FusterJJ, Sanz-GonzalezSM, MollUM, et al.. Classic and novel roles of p53: prospects for anticancer therapy. Trends Mol Med, 2007, 13(5): 192-199

[27] ParkKR, NamD, YunHM, et al.. beta-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett, 2011, 312(2): 178-188

[28] ZhuJF, LiZJ, ZhangGS, et al.. Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3/AKT signalings. PLoS One, 2011, 6(8): e23720